The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 28, 2017

Filed:

Oct. 04, 2010
Applicants:

Ana Martínez Gil, Madrid, ES;

Carmen Gil Ayuso-gontan, Madrid, ES;

Valle Palomo Ruiz, Madrid, ES;

Daniel Perez Fernandez, Madrid, ES;

Concepción Perez Martín, Madrid, ES;

Ana María Perez Castillo, Madrid, ES;

María Isabel Loza Garcia, Santiago de Compostela, ES;

María Isabel Cadavid Torres, Santiago de Campostela, ES;

José Brea Floriani, Santiago de Compostela, ES;

Inventors:

Ana Martínez Gil, Madrid, ES;

Carmen Gil Ayuso-Gontan, Madrid, ES;

Valle Palomo Ruiz, Madrid, ES;

Daniel Perez Fernandez, Madrid, ES;

Concepción Perez Martín, Madrid, ES;

Ana María Perez Castillo, Madrid, ES;

María Isabel Loza Garcia, Santiago de Compostela, ES;

María Isabel Cadavid Torres, Santiago de Campostela, ES;

José Brea Floriani, Santiago de Compostela, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01); A01N 43/40 (2006.01); A61K 31/44 (2006.01); A61K 31/41 (2006.01); A01N 43/82 (2006.01); C07D 285/08 (2006.01); A61K 31/433 (2006.01);
U.S. Cl.
CPC ...
C07D 285/08 (2013.01); A61K 31/433 (2013.01);
Abstract

The present invention is based on the use of a broad family of 5-imino-1,2,4-thiadiazoles as potential new drugs for the treatment of diseases in which PDE7 inhibition is important, specially inflammatory diseases, autoimmune and neurodegenerative disorders. On the other hand, compounds of the 5-imino-1,2,4-thiadiazole family are here described, as well as their synthetic procedures, and they may have great application as drug or drug candidates. Therefore, a first aspect of the present invention is related to a compound of formula (I):


Find Patent Forward Citations

Loading…